BOSTON, Ma. (November 14, 2018)—In search of a cure, several hundred leaders representing different aspects of the veterinary, pediatric, oncology, and the pharma industry came together for the Canines-N-Kids Foundation’s Paws for a Cure Research Symposium co-hosted by Merck at its Research Laboratories in Boston to discuss ways to accelerate cancer drug development for cancers that children and canines both develop. Canines-N-Kids Foundation is a nonprofit committed to promoting research that integrates efforts for the benefit of both kids and dogs with cancer.

CnK Advisory Board member Dr. Keila Torres is cancer surgeon at MD Anderson, and the mother of three Labrador retrievers and the author of the Sniffing for a Cure Blog and Guest Author of the CnK Blog this month, describing the devastating cancer our pets and kids share, and the efforts of the Paws for a Cure Symposium to help us Crush Cancer @ Both Ends of the Leash

At UC Davis, hundreds of dogs are participating in clinical trials of novel cancer treatments that certainly have application in animal medicine, but possibly in human medicine as well. Veterinary oncology is a field that extends animal research outside the vivarium deep into the public realm, with fascinating possibilities for human medicine.